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Background: Mixed cryoglobulinemia (MC) in hepatitis C virus (HCV) infection is associated with abnormal immune
responses mediated by T cells and B cells, while the relationships of different subsets of CD4 + T helper (Th) cells, B
cells and associated cytokines with type III asymptomatic MC in HCV infection are poorly understood.
Methods: Fifty-four chronic hepatitis C (CHC) patients and 23 healthy controls (HCs) were enrolled in the study.
Serum cryoglobulins were detected by cryoprecipitation. The types of cryoglobulin were determined by western
blot. The phenotypes and frequencies of Th cell and B cell subsets were detected by flow cytometric analysis. The
cytokines IFN-γ, IL-4, IL-17, IL-21, IL-22, and TGF-β were measured by enzyme-linked immunosorbent assay.
Results: Twenty-six CHC patients were detected with type III asymptomatic MC. The frequencies of Th2, Th17,
follicular helper T (Tfh cells), Th22, and tissue-like B cells were significantly higher in CHC patients compared to HCs,
while these cell subsets were not significantly different between CHC patients and HCV-related MC patients. The
frequencies of Th1 and activated memory B cells increased in HCV-related MC patients compared to HCs, although
the difference between the two cell subsets in CHC patients and HCs was not significant. The frequency of regulatory
T cells (Treg cells) was higher in CHC patients than in HCV-related MC patients and HCs. Higher expressions of serum
IFN-γ, IL-17, IL-21, and IL-22 were observed in CHC patients than in HCs, but the differences were not significantly different
in CHC patients and HCV-related MC patients. The frequency of Th1 cells was associated with activated memory B cells in
HCV-related MC patients, and the frequency of Th1 cells and activated memory B cells was closely related to HCV RNA in
HCV-related MC patients.
Conclusions: The increased frequencies of Th17 cells, Tfh cells, Th22 cells, Treg cells, cytokines IL-17, IL-21, IL-22, and
tissue-like B cells, were related to HCV infection but not type III asymptomatic MC. Higher frequencies of Th1 cells
and activated memory B cells were associated with type III asymptomatic MC in HCV infection.
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Table 1 Baseline characteristics of CHC patients, HCV-related
MC patients, and HC
Parameters CHC HCV-related MC HC
Number of subjects 28 26 23
Age (years), mean ± SD 53.6 ± 6.7 55.5 ± 7.1 52.0 ± 8.6
Sex, male/female 16/12 14/12 13/10
ALT, mean ± SD 25.8 ± 25.3 27.5 ± 26.2 23.6 ± 18.1
Genotype (1b) 28 26 —
Type of cryoglobulin — III —
HCV-RNA (log10 IU/mL),
mean ± SD
6.81 ± 0.56 6.45 ± 0.94 —
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Chronic hepatitis C virus (HCV) infection is not only re-
sponsible for hepatic diseases but is also associated with
several extrahepatic manifestations. Mixed cryoglobuli-
nemia (MC), an autoimmune disease characterized by
the formation of cold-precipitable cryoglobulin com-
plexes composed of immunoglobulins, is recognized as
the most common extrahepatic disease induced by HCV
infection [1, 2]. Based on the immunoglobulin compos-
ition, MC has two types of cryoglobulins: Type II cryo-
globulins consisting of polyclonal IgG and monoclonal
IgM with rheumatoid factor (RF) activity, and type III cryo-
globulins characterized by polyclonal IgG with polyclonal
IgM. In HCV-related MC, the majority of patients have
asymptomatic MC, and only 10 –15 % of these patients will
develop cryoglobulinemic symptoms, characterized by
small vessel vasculitis, glomerulo-nephritis, and neuropathy
due to immune complex deposition and activation of the
complement cascade in small blood vessels [3, 4].
To date, the involvement of host immune responses me-
diated by T cells and B cells with MC in chronic hepatitis C
(CHC) patients is poorly understood. Several cytokines and
chemokines, including IL-6, TNF-α, IL-1β, IFN-γ, MIP-1α,
CXCL9, CXCL10, and CXCL11 associated with T helper
(Th) 1 immune responses, were found to be involved in
HCV-related type II MC [5–13], especially in patients with
autoimmune thyroiditis or active vasculitis. Theoretically,
agents that selectively neutralize molecules such as
CXCL10, might increase patient responsiveness to HCV
therapy [14]. Recent evidence also showed a deficiency of
CD4 +CD25+ regulatory T (Treg) cells in HCV-related
MC patients with active vasculitis [15]. In addition, a highly
restricted T cell receptor variable β gene repertoire in liver
and peripheral blood was found in HCV-related MC pa-
tients, suggesting that the clonally expanded TCR Vβ reper-
toire was associated with HCV-related MC [16].
MC is considered to be a benign B-cell proliferative
disorder. The expansion of IgM + CD27 + CD21-B cells,
which express VH1-69 and VH4-34 genes, are present in
type II MC patients with HCV infection [17, 18], and ef-
fective treatment for HCV-related MC decreased the
number of VH1-69 + B cells [19]. In addition, the expan-
sion of immature B cell subsets and activated memory B
cells with distinct activated markers such as CD86 and
CD71 were noted in HCV-related MC patients [20]. In
contrast, naive B cells in MC patients with HCV infec-
tion are decreased because they have a higher sensitivity
to apoptosis, and treatment of MC with rituximab re-
stored normal B cell compartments [21]. This suggested
that B cells play an important role in the pathogenesis of
MC with HCV infection.
Th cell subsets such as Th2 cells (IL-4 + CD4 + T
cells), Th17 cells (IL-17 + CD4 + T cells), Th22 cells (IL-
22 + CD4+ T cells) and Treg cells are associated withHCV infection [22–25]. To our knowledge, no study has
evaluated the immune phenotype of Th cell subsets and
their relationship with B cells in CHC patients with type
III asymptomatic MC. The identification of immuno-
logical markers associated with T and B cell immune re-
sponses in type III asymptomatic MC may help to
improve clinical monitoring and disease management.
To characterize the features and relationships of periph-
eral Th cell and B cell subsets in CHC patients with type
III asymptomatic MC, 26 CHC patients with type III
asymptomatic MC, 28 CHC patients without MC and 23
sex- and age-matched healthy controls (HCs) were en-
rolled in the study. We analyzed different immune cell
subsets and Th cell cytokines to identify distinct pheno-
types associated with type III asymptomatic MC in HCV
infection.
Results
Increased percentage of Th1 cells in type III
asymptomatic MC with HCV infection
Among 54 CHC patients, 26 CHC patients were tested
positive for type III MC, and none of these MC patients
had cryoglobulinemic syndrome (Table 1). To assess the
potential role of different subsets of T cells, especially
Th cell subsets, in type III asymptomatic MC with HCV
infection, total T cells, CD4+ T cells, and CD4+ T cell
subsets, including Th1 cells (IFN-γ + CD4+ T cells), Th2
cells, Th17 cells, Th22 cells, and Treg cells (CD4 +
CD25 + Foxp3+ cells) were analyzed in CHC patients,
HCV-related MC patients, and HCs. We did not note
any difference in the frequencies of CD3+ T cells and
CD4+ T cells in the three groups (Fig. 1b-c). The fre-
quency of Th1 cells in total CD4+ T cells was signifi-
cantly higher in MC patients compared with HCs
(Fig. 1d). Though a higher frequency of Th1 cells was
found in CHC patients, the difference was not signifi-
cant between CHC patients and HCs. The percentages
of Th2 cells, Th17 cells, and Th22 cells in total CD4+ T
cells were increased in both CHC patients and HCV-
related MC patients compared with HCs (Fig. 1e-g). The
frequencies of Th2 cells, Th17 cells, and Th22 cells were
Fig. 1 Frequencies of CD4 + T cell subsets in CHC patients and HCV-related asymptomatic MC patients. a The gating strategy for T cell subsets by
flow cytometric analysis. b The frequencies of total T cells. c The frequency of CD4 + T cells in total T cells. d, e, f g, h, and i show the frequencies
of IFN-γ + CD4+ T cells, IL-4 + CD4+ T cells, IL-17 + CD4+ T cells, IL-22 + CD4+ T cells, IL-21 + CD4+ T cells, and Treg cells (CD4 + CD25 + Foxp3+ cells) in
total CD4+ T cells. j Shows the ratio of Th1 cells to Th2 cells. *p <0.05
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HCV-related MC patients, suggesting that higher fre-
quencies of Th2 cells Th17 cells, and Th22 cells wereassociated with HCV infection but were not related to
MC. CD4+ T cells are a main source of IL-21, a cytokine
responsible for the activation and differentiation of T
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quency of IL-21 + CD4+ T cells in three groups, and
found their percentage was increased in CHC patients and
HCV-related MC patients (Fig. 1h). However, there was
no correlation between the frequency of IL21 + CD4+ T
cells and MC. We next detected the frequency of Treg
cells in three groups, and found their frequency was
higher in CHC patients than in HCV-related MC patients
and HCs. However, the frequency of Treg cells was not
significantly different between HCV-related MC patients
and HCs (Fig. 1i). The ratio of Th1 cells/Th2 cells was also
examined in three groups, but there was no significant dif-
ference among these groups (Fig. 1j). Taken together, these
results indicated that Th2 cells, Th17 cells, Th22 cells,
IL21 + CD4+ T cells, and Treg cells were only associated
with HCV infection but not MC, while Th1 cells were re-
lated to type III MC in HCV infection.Increased frequency of activated memory B cells in type
III asymptomatic MC with HCV infection
Current studies have reported abnormal B cells in type
II MC with HCV infection [17, 18, 20], while few studies
have investigated the characteristics of B cells in HCV-
related type III asymptomatic MC. As shown in Fig. 2b,
the frequencies of total B cells and memory B cells
(CD27+ B cells) were decreased in CHC patients. The
frequencies of total B cells and memory B cells were
comparable between CHC patients and HCV-related
MC patients. Measurement of activated B cells, includ-
ing tissue-like B cells (CD27-CD21- B cells) and acti-
vated memory B cells (CD27 + CD21- B cells) in three
groups indicated the frequency of tissue-like B cells were
increased in both CHC patients and HCV-related MC
patients (Fig. 2c), but the difference of percentages of tis-
sue like B cells in CHC patients and HCV-related MC
patients was not significant. The percentage of activated
memory B cells was only increased in HCV-related CHC
patients compared with HCs. Because the increased ex-
pression of CD86 and CD95 is associated with B cell ac-
tivation [28], we detected the expression of CD86 and
CD95 in B cell subsets. We found that the increased fre-
quencies of CD86 + CD27- B cells and CD95 + CD27- B
cells were comparable in CHC patients and HCV-related
MC patients, compared to HCs (Fig. 2d-e). Increased
percentages of CD86 + CD27+ B cells and CD95 + CD27
+ B cells were observed in HCV-related MC patients but
not in CHC patients when compared with HCs. More-
over, in HCV-related MC patients, the frequency of acti-
vated memory B cells was positively correlated with
CD95 + CD27+ B cells (Fig. 2f ). These findings indicate
that the increased frequencies of tissue-like B cells are
associated with HCV infection, while activated memory
B cells with an increase percentage of CD95 + CD27+ Bcells is related to type III asymptomatic MC in HCV
infection.
Increased frequency of circulating Tfh cells is associated
with HCV infection but not type III asymptomatic MC
Tfh cells (CXCR5 + CD4+ T cells), a major subset of ef-
fector CD4 + T cells, are associated with the production
of IL-21 and are responsible for the activation and differ-
entiation of B cells [29]. In peripheral blood, circulating
Tfh cells were characterized by CXCR5 with ICOS or
PD-1, and could be divided into different subsets based
on the expression of IFN-γ, IL-4 and IL-17 [30]. Previous
studies showed that Tfh cells were associated with HCV
infection and autoimmune diseases [28, 31, 32]. Whether
Tfh cells are related to type III asymptomatic MC in
HCV infection is well understood. We examined the fre-
quencies of different Tfh cell subsets in the three patient
groups. As shown in Fig. 3b-d, the frequencies of
CXCR5 + CD4+ T cells, PD-1 + CXCR5 + CD4+ T cells
and ICOS + CXCR5 + CD4+ T cells in CHC patients and
HCV-related MC patients were significantly higher than
in HCs, although the frequencies of these Tfh cell sub-
sets were not statistically different in CHC patients and
HCV-related MC patients. We further measured differ-
ent Tfh subsets including IFN-γ + Tfh cells, IL-4+ Tfh
cells, IL-17+ Tfh cells, and IL-21 + Tfh cells (Fig. 3e).
The results showed that IFN-γ +Tfh cells, IL-4+ Tfh cells,
and IL-21+ Tfh cells were associated with HCV infection
but not MC. In addition, the frequencies of IL-17+ Tfh
cells were comparable in the three groups. Taken together,
these results suggest that Tfh cell subsets are associated
with HCV but are not involved in type III asymptomatic
MC with HCV infection.
Increased expressions of IFN-γ, IL-17, IL-21, and IL-22 are
associated with HCV infection but not type III asymptom-
atic MC
We next detected the cytokines IFN-γ, IL-4, IL-17, IL-
21, IL-22, and TGF-β, which are associated with im-
mune responses of Th1 cells, Th2 cells, Th17 cells, Tfh
cells, Th22 cells, and Treg cells. As shown in Fig. 4a-d,
the expressions of IFN-γ, IL-17, IL-21, and IL-22 were
higher in CHC patients and HCV-related MC patients
than in HCs, although this was not significant between
CHC patients and HCV-related MC patients. Compared
with HCs, the expression of TGF-β was lower in CHC pa-
tients and HCV-related MC patients, but was not signifi-
cantly different between CHC patients and MC patients
with HCV infection (Fig. 4e). Because the expressions of
IL-4 in most subjects from the three groups were below
the detection limit of the enzyme-linked immunosorbent
assay (ELISA) kit (15.6 pg/mL), and we could not distin-
guish differences in IL-4 expression levels (data not shown).
In summary, these results suggested that abnormalities of
Fig. 2 Frequencies of B cell subsets in CHC patients and HCV-related asymptomatic MC patients. a The gating strategy for B cell subsets by flow
cytometric analysis. b The frequencies of total B cells and memory B cells. The frequencies of c CD21- B cells in CD27- B cells and CD27+ B cells;
d CD86+ B cells in CD27- B cells and CD27+ B cells; and e CD95+ B cells in CD27- B cells and CD27+ B cells. f The relationships between the
frequency of CD27 + CD21- B cells, CD86 + CD27 + IgG+ B cells and CD95 + CD27 + IgG+ B cells.*p <0.05
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Fig. 3 Frequencies of circulating Tfh cell subsets in CHC patients and HCV-related asymptomatic MC patients. a The gating strategy for circulating
Tfh cell subsets by flow cytometric analysis. b Frequency of circulating Tfh cells in CD4 + T cells. c Frequency of PD-1+ Tfh cells in CD4+ T
cells. d Frequency of ICOS+ Tfh cells in total CD4+ T cells. e Frequencies of Tfh1 (IFN-γ + Tfh) cells, Tfh2 (IL-4+ Tfh) cells, Tfh 17 (IL-17+ Tfh)
cells, and IL-21+ Tfh in total Tfh cells. *p <0.05
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lated to HCV infection but not associated with type III
asymptomatic MC.Frequency of Th1 cells is positively correlated with the
frequency of activated memory B cells in HCV-related
asymptomatic MC
Next we analyzed the relationship of the frequencies of
different subsets of CD4+ T cells with B cell subsets in
HCV-related asymptomatic MC. The frequency of Th1
cells was positively related to the percentage of activated
memory B cells in MC patients with HCV infection
(Fig. 5a). However, there were no statistically significant
associations of Th1 cells with CD86 + CD27+ B cells or
CD95 + CD27+ B cells in HCV-related MC patients
(Fig. 5b-c). Together, the results indicated that Th1 cells
were associated with the activation of memory B cells,
but were not related to the expression of activationFig. 4 Expressions of serum cytokines in CHC patients and HCV-related asy
IFN-γ, IL-17, IL-21, IL-22, and TGF-β detected by ELISA. *p <0.05markers CD86 and CD95 in asymptomatic MC with
HCV infection.
Frequency of Th1 cells, activated memory B cells are
associated with HCV RNA in type III MC
We further measured the relationship of Th1 cells and
activated memory B cells with clinical parameters in
HCV-related asymptomatic MC patients. We found the
frequencies of Th1 cells and activated memory B cells
were positively related to HCV RNA in MC patients
with HCV infection (Fig. 6a-b). In HCV-related MC pa-
tients, the frequencies of CD86 + CD27+ B cells and
CD95 + CD27+ B cells were not significantly associated
with HCV RNA (Fig. 6c-d). In CHC patients without
MC, we failed to detect significant associations of Th1
cells, activated memory B cells, CD86 + CD27+ B cells
and CD95 + CD27+ B cells with HCV RNA. We also
tested the relationship of alanine transaminase (ALT), a
marker of inflammatory necrosis in the liver, with themptomatic MC patients. a, b, c, d and e show the expression of serum
Fig. 5 Relationship between frequency of Th1 cells and activated memory B cells in HCV-related asymptomatic MC patients. The relationship of
a IFN-γ + CD4+ T cells with CD27 + CD21- B cells; b IFN-γ + CD4+ T cells with CD86 + CD27+ B cells; and c IFN-γ + CD4+ T cells with CD95 +
CD27+ B cells
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CHC patients and HCV-related asymptomatic MC pa-
tients, but the results showed no significant association
(Fig. 6e-h). In summary, these results suggested that
HCV may have a significant influence on the presence
of abnormal Th1 cells and activated memory B cells in
type III asymptomatic MC.
Discussion
Although MC in HCV infection is associated with ab-
normal immune responses mediated by T cells and B
cells, the relationships of different subsets of CD4+ T
cells and B cells with type III asymptomatic MC in HCV
infection is not well explored. We found increased fre-
quencies of Th1 cells and activated memory B cells in
HCV-related type III asymptomatic MC. In addition, the
frequency of Th1 cells was positively related to activated
memory B cells in HCV-related MC. Moreover, the two
target cell subsets were associated with HCV RNA in
MC patients with HCV infection.
MC is considered an autoimmune disease, and im-
mune disorders mediated by T cells have been investi-
gated by different research groups. Although reports
from Cacoub et al. and Sansonno et al. showed no sig-
nificant difference in the frequency and activation of T
cells in CHC patients and MC patients with HCV infec-
tion [33, 34], it is still unknown whether Th cell subsets
are involved in the pathogenesis of HCV-related type III
asymptomatic MC. In this study, we investigated the re-
lationship of Th cell subsets with HCV-related type III
MC without cryoglobulinemic symptoms, and found
that Th2 cells, Th17 cells, Th22 cells and IL-21 + CD4+
T cells, were only associated with HCV infection but not
MC. A higher frequency of Th1 cells was observed in
HCV-related MC patients but not CHC patients in com-
parison to HCs, implying that immune responses medi-
ated by Th1 cells might have an important role in theprogression of HCV-related MC. Previous studies
showed that Treg cells were increased in CHC patients
[25], while Boyer et al. observed a deficiency of CD4 +
CD25+ Treg cells in HCV-related MC patients with active
vasculitis compared with CHC patients without MC and
HCs [15]. In this study, we found a higher frequency of
Treg cells in CHC patients, while a reduced the frequency
of Treg cells was observed in MC. In addition, we did not
observe a deficiency of Treg cells in HCV-related MC pa-
tients without cryoglobulinemic symptoms compared to
HCs. The difference between the study by Boyer et al. and
our results might be due to the presence or absence of
cryoglobulinemic symptoms, which might enhance the in-
hibition of Treg cells in HCV-related MC patients.
Abnormalities of different subsets of B cells, including
immature B cells, tissue-like B cells and memory B cells
have been described in MC [17, 18, 20, 21], in studies
largely focused on type II MC with cryoglobulinemic
symptoms in HCV infection. We investigated different B
cell subsets in HCV-related type III asymptomatic MC,
and found that the frequency of memory B cells was re-
duced, while the percentage of tissue-like B cells was in-
creased in HCV infection. These results are consistent
with previous studies [35–37]. In the current study, only
activated memory B cells with increased expression of
activation markers CD86 and CD95 were associated with
HCV-related type III asymptomatic MC. Although the
features and functions of activated memory B cells, spe-
cifically IgM+ memory B cells, has been elucidated in
type II MC with HCV infection [17, 18], their exact
function in MC patients is still unclear. The composition
of cryoglobulins in type III MC is polyclonal IgG and
polyclonal IgM, and IgG from memory B cells with class
switching [38]. Thus, we hypothesized that activated
memory B cells might be a main source of polyclonal
IgG in cryoglobulins in type III MC patients with HCV
infection.
Fig. 6 Relationships between frequencies of Th1 cells and activated memory B cells with HCV RNA in CHC patients and HCV-related asymptomatic MC
patients. a Relationship of Th1 cells with HCV RNA in CHC patients and MC patients with HCV infection. b Relationship of CD27 + CD21- B cells with HCV
RNA in CHC patients and HCV-related MC patients. c Relationship of CD86 + CD27+ B cells with HCV RNA in CHC patients and MC patients with
HCV infection. d Relationship of CD95 + CD27+ B cells with HCV RNA in CHC patients and HCV-related MC patients. e Relationship of Th1 cells
with ALT in CHC patients and MC patients with HCV infection. f Relationship of CD27 + CD21- B cells with ALT in CHC patients and HCV-related
MC patients. g Relationship of CD86 + CD27+ B cells with ALT in CHC patients and MC patients with HCV infection. h Relationship of CD95 + CD27+ B
cells with ALT in CHC patients and HCV-related MC patients
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and differentiation of B cells [29], and are involved in
HCV infection and autoimmune diseases [28, 31, 32, 39],
we speculated that abnormal memory B cell activation
may be associated with Tfh cells in HCV-related MC. Un-
expectedly, we found higher frequencies of Tfh cell subsets
in CHC patients and HCV-related MC patients, and Tfh
cells were not related to type III asymptomatic MC. In
vivo activation of B cells is dependent on BCR stimulation,
coupled with help from Tcells via coupling of CD40L with
CD40 on B cells and cytokine secretion by T cells, or relies
on endogenous TLR ligand stimulation [40]. Studies by
Charles et al. and Terrier et al. showed that activated
memory B cells were anergic to BCR- and CD40-mediated
stimulation but not TLR9 triggering in HCV-related MC
patients [18, 41], implying endogenous TLR ligands but
not Tfh cells were responsible for the aberrant activation
of memory B cells in HCV-related MC.
Because the diverse functions of Th cells are mainly
determined by the cytokines they produce, we investi-
gated cytokines associated with Th1 cells, Th2 cells,
Th17 cells, Tfh cells, Th22 cells, and Treg cells in the
three patient groups. We found that the expression of
IL-17, IL-21, and IL-22 was increased in CHC patients
and HCV-related MC patients, consistent with the fre-
quencies of Th17 cells, Tfh cells and Th22 cells in these
patients. We also found the expression of IFN-γ was
higher in both CHC patients and HCV-related MC pa-
tients, but it was not related to the frequency of Th1
cells in these patients compared to HCs. Furthermore,
the expression of TGF-β was lower in CHC patients and
HCV-related MC patients, which was also not related to
the frequencies of Treg cells in these patients. However,
IFN-γ and TGF-β are not only produced by T cells, but
can also be secreted by many different types of cells such
as professional antigen-presenting cells [42, 43]; thus,
IFN-γ and TGF-β from other type cells might have a sig-
nificant effect on the concentration of serum IFN-γ and
TGF-β in CHC patients. Although the prevalence of
IFN-γ and other cytokines associated with Th1 immune
responses have been observed in CHC patients with
MC, other studies mainly focused on MC with cryoglo-
bulinemic symptoms. Our results suggested that type III
asymptomatic MC is only associated with a higher fre-
quency of Th1 cells but was not related to IFN-γ in
HCV infection. To better understand the effect of cryoglo-
bulinemic symptoms on the expression of Th1 cells, IFN-
γ and cytokines associated with Th1 immune responses in
HCV-related MC patients should be investigated further
by enrolling CHC patients with symptomatic MC in future
studies. Our results are consistent with Zhang et al., who
found the expression of TGF-β was lower in CHC patients
[44], although other studies detected no difference or a
higher expression of serum TGF-β levels in CHC patientscompared to HCs [45, 46]. This suggested that the diver-
gent genetic background of the study population might
have an effect on serum TGF-β levels in HCV infection.
MC inhibits the expression of Treg cells, but the exact
mechanism is still unknown. TGF-β has critical roles in
the differentiation and function of Treg cells [47]; how-
ever, a relationship between TGF-β and Treg cells in
HCV-related MC patients is not well understood. In the
study, we did not find a similar change of TGF-β expres-
sion with frequency of Treg cells in HCV-related MC pa-
tients compared to CHC patients, implying that MC
might induce the reduction and dysfunction of Treg cells
in a non-TGF-β-dependent manner.
We next evaluated the relationships among Th1 cells,
activated memory B cells, and clinical parameters in
HCV-related asymptomatic MC. The frequency of Th1
cells was associated with activated memory B cells in
MC patients with HCV infection, suggesting the im-
mune response mediated by Th1 cells might contribute
to memory B cell activation in HCV-related asymptom-
atic MC. In addition, the percentages of Th1 cells and
activated memory B cells were related to HCV RNA but
not ALT levels in HCV-related MC patients. In CHC
patients without MC, the relationship of Th1 cells
and activated memory B cells with HCV RNA load
was not statistically significant. In chronic HCV infec-
tion, changes in Th1 cells and activated memory B
cells may gradually increase to levels that contribute
to the development of MC disorder and until the
stage where type III MC develops. Therefore, the ef-
fect of virus infection on Th1 cells and activated
memory B cells should be determined.Conclusion
This study highlights that a higher frequency of Th1
cells is associated with memory B cell activation in
HCV-related type III MC without cryoglobulinemic
symptoms. HCV RNA load is closely associated with
Th1 cells and activated memory B cells in asymptom-
atic MC patients with HCV infection. Although a
small sample number of patients is tested, our obser-
vations indicate that alterations in the frequency of
Th1 cells and activated memory B cells might play an
important role in the development of type III asymptom-
atic MC with HCV infection. Th1 cells and activated
memory B cells in HCV-infected type III asymptomatic
MC patients might also be used as biomarkers for clin-
ical monitoring and disease management. To under-
stand the complex function of Th cells and B cells in
MC with HCV infection, further investigations are war-
ranted, by using a larger population and enrolling
HCV-related MC patients with cryoglobulinemic syn-
drome in our future studies.
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Patients and controls
Twenty-six CHC patients with type III MC and 28 CHC
patients without MC, and 23 HCs were enrolled in the
study (Table 1). All CHC patients were infected with
genotype 1b HCV. Cryoglobulinemia was defined as the
presence of circulating cryoglobulins [48], and the type
of cryoglobulins was assessed by western blot assay.
Clinical manifestations of cryoglobulinemic syndrome
such as vessel vasculitis, glomerulo-nephritis, and neur-
opathy were not observed in these MC subjects. Liver fi-
brosis was evaluated by liver stiffness measurement
(FibroScan®, Echosens, Paris, France) [49], and none had
severe fibrosis or cirrhosis. All subjects were negative for
hepatitis B virus or human immunodeficiency virus in-
fection. This study was approved by the ethics commit-
tee of Peking University People’s Hospital and written
informed consent was obtained from all subjects.
Clinical tests and peripheral blood mononuclear cell
(PBMC) preparation
HCV antibodies, HCV RNA, and HCV genotypes were
tested as described previously [49, 50]. PBMCs were iso-
lated by density gradient centrifugation with Ficoll-Paque
Plus (GE Health Bio-science, AB, Sweden) as described by
Guo et al. [51]. PBMCs were stored in liquid nitrogen until
ready for analysis.
Detection and characterization of cryoglobulins
To detect cryoglobulins, blood was drawn into pre-
warmed vacutainer tubes and maintained at 37 °C until
the serum was separated. Then serum was incubated at
4 °C for one week and then examined daily for the
presence of cryoprecipitate. After the serum containing
cryoprecipitate was spun in a centrifuge for 15 min at
4 °C, the supernatant was removed, and the pellet was
vortexed in ice-cold PBS three times. The sample was
then resuspended in 1 mL PBS and re-dissolved by in-
cubation at 37 °C for 1 h. To determine the type of
cryoglobulins, western blot was performed, following
an established protocol, with antibodies for IgM, IgG,
IgA, Lambda and Kappa chains (SouthernBiotech, Bir-
mingham, USA) [52].
Flow cytometric analysis
Phenotypic analyses of T cells and B cells were per-
formed with anti-human monoclonal antibodies (mAbs):
anti-human CD3-PerCP, CD4-FITC, CD19-PerCP and
CD21-APC were from BD Biosciences (San Jose, CA,
USA). CXCR5-APC, ICOS-PE, PD-1-PE, IFN-γ-PE, IL-
4-PE, IL-17-PE, IL-21-PE, IL-22-PE, CD27-FITC, CD86-
PE, CD95-PE, CD25-APC, and Foxp3-PE antibodies
were obtained from eBiosciences (San Diego, CA, USA).
Cells were analyzed by flow cytometry (BD FACSCalibur,San Jose, CA) and data was analyzed by FlowJo software
(Tree Star, San Carlos, CA).
Intracellular cytokine staining
PBMCs were stimulated with 50 ng/mL of phorbol-12-
myristate-13-acetate (PMA) and 1 μg/mL of ionomycin
(Sigma-Aldrich, St. Louis, USA), in the presence of 1 μl/
ml GolgiStop™ (BD Biosciences) at room temperature
for 4 h. After washing twice with PBS containing 0.5 %
fetal bovine serum, the cells were stained with CD3-
PercP, CD4-FITC with or without CXCR5-APC at room
temperature in the dark for 20 min. Cells were fixed and
permeabilized with Fixation/Permeabilization solution
(BD Biosciences) at 4 °C for 20 min. After washing two
times in 1× BD Perm/Wash™ buffer, the cells were incu-
bated at room temperature for 20 min with IFN-γ-PE,
IL-4-PE, IL-17A-PE, IL-21-PE, and IL-22-PE antibodies
or isotype controls. For staining of Foxp3 in CD4 + CD25
+ T cells sorted from PBMCs, Foxp3/Transcription Factor
Staining Buffer Set (eBioscience) was used, and detection
followed the manufacturer’s instructions.
ELISA
The serum concentration of cytokines IFN-γ, IL-4, IL-
17, IL-22, and TGF-β were detected by human ELISA
kit (UCallM Biotech Co., Ltd, Wuxi, China). The detec-
tion range of IFN-γ, IL-4, IL-17, and IL-22 was from
15.6 to 1000 pg/mL. The detection range of TGF-β was
from 31.3 to 2000 pg/mL. Human IL-21 ELISA kit was
from eBiosciences, and the detectable concentration was
78 to 5000 pg/mL. The detection of each cytokine was
in accordance with the manufacturer’s instructions.
Statistical analysis
Statistical analysis was by Student’s t-test, ANOVA or
Mann–Whitney U-test according to data distribution
using version 16.0 SPSS software (SPSS Inc. Chicago, IL,
USA). The data are presented as the mean ± standard
deviation (SD). Analysis of correlation between variables
was performed by linear regression analysis with Prism
Version 5 software (GraphPad). A p value <0.05 was
considered statistically significant.
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